Study on the Chronic and Acute Effects of Nordic Berry Beverage on Cognitive Function (NCT05693441) | Clinical Trial Compass
CompletedNot Applicable
Study on the Chronic and Acute Effects of Nordic Berry Beverage on Cognitive Function
Sweden62 participantsStarted 2023-01-17
Plain-language summary
The aim of the current study is to investigate whether acute and 12-weeks daily intake of Nordic berries can improve cognitive abilities of adults without cognitive disease, and whether the effect can be linked to changes in metabolic parameters.
Who can participate
Age range
60 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Age 60-85 years.
. Capable and willing to give written informed consent.
. Capable and willing to perform cognitive testing in Swedish (mastering the Swedish language, functional vision and hearing or the use of visual or hearing aids during testing).
. Capable and willing to ingest the study beverage for 12 weeks and to follow the instructions given.
. Agree to maintain consistent dietary habits and physical activity levels for the duration of the study
Exclusion criteria
. Known to be affected by major neurocognitive disorder/dementia or low score on cognitive screening test (Mini Mental State Examination (MMSE) score less than 24.
. Affected by other medical condition(s) or medication(s) known to significantly affect cognitive function.
. Past history of brain damage, significant head trauma (including loss of consciousness as a result), brain surgery or stroke.
. Underweight (BMI \<18.5).
. Significant psychiatric disorders with current symptoms.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Cognitive measures-memory
Timeframe: Change from baseline following 12 weeks daily consumption, compared to control
2
Cognitive measures-memory
Timeframe: Change from baseline following 12 weeks daily consumption, compared to control
3
Cognitive measures - memory
Timeframe: Change from baseline at 1.5 hours post-dose, and 12 weeks daily consumption, compared to control
4
Cognitive measures - memory
Timeframe: Change from baseline at 1.5 hours post-dose, and 12 weeks daily consumption, compared to control
5
Cognitive measures - executive function
Timeframe: Change from baseline at 1.5 hours post-dose, and 12 weeks daily consumption, compared to control
6
Cognitive measures - executive function
Timeframe: Change from baseline at 1.5 hours post-dose, and 12 weeks daily consumption, compared to control